TGFB1 and Miyoshi myopathy: Here, our recent data determine the role of stroma-produced TGFβ in CXCL13 up-regulation in the MM milieu and suggest that TGFβ blockade using novel inhibitors may result in CXCL13 suppression and BM microenvironment normalization.